Crown Laboratories Appoints New GM of Premium Skincare Business Unit

Crown Laboratories has hired June Risser to serve as general manager, premium skincare.  She will lead the global business unit which includes StriVectin and Vita Liberata, and she will hold a position on the executive leadership team.

Risser is a skin care expert and digital innovator with a proven track record of growing businesses and brands and has worked in both the US and UK. Prior to Crown, she was general manager at Galderma Laboratories where she led the dermatologist-recommended skin care brands Cetaphil and Differin in the US, doubling the business under her leadership.

For her efforts in social media and influencer marketing on Cetaphil, Risser was named by Glossy Magazine as a Top 50 Beauty Executive of the Year in 2021. She is also an Rx to OTC switch expert, having led the Differin launch after gaining FDA approval, growing it to the No. 3 brand in retail acne. 

Prior to Galderma, she spent twelve years at Reckitt, a global consumer products company, where she led iconic power brands including Lysol and Clearasil.

Risser also has experience advising CEOs and CMOs across industries on marketing and growth strategies while she was a management consultant at Vivaldi Partners and Mitchell Madison Group. She holds a B.A. magna cum laude in politics from Princeton University and earned her Master's in Public Policy from Harvard University.

“It is with great pleasure that we officially welcome June to the Crown team. I am confident that she will leverage her skincare and business-building experience to achieve sustainable, long-term growth in the premium skincare business,” said Jeff Bedard, president and CEO at Crown.

Crown acquired StriVectin in 2021.